Fill in your data to receive the webinar on Data Governance
The implementation of ISO IDMP (and DADI), affects pharmaceutical companies in many aspects (process, organisational, technology and data). One of the key organisational aspects is Data Governance.
While in many pharmaceutical companies, the Regulatory Affairs department is responsible for IDMP, the data required, originates from other sources and departments. The need to collect and maintain IDMP data (e.g. ingredients, supply chain, indications), require clear Governance for the entire organisation.
With our experience and unique subject matter expertise of Regulatory and Life Sciences, we can accelerate the set-up and implementation of Data Governance.
During this webinar we will present our experience on Data Governance, and we share the challenges we have seen in various companies.
During this webinar we elaborated on:
- The relevance of Data Governance
- The impact of IDMP on your Organization's Data Governance
- Benchmark of Data Governance in pharmaceutical industry
- Current challenges in Data Governance
- How to implement/start with Data Governance
This webinar was hosted by our experts Patrick Middag and Dennie van de Voort. Patrick Middag
is a Director at Deloitte , with a focus on Regulatory Information Management and IDMP. He joined Deloitte after a career of more than 20 years in the pharmaceutical industry, including 14 years at Bristol Myers Squibb, where he was an Associate Director in IT for Global Regulatory Sciences. Dennie van de Voort
is a Junior Manager at Iperion, a Deloitte business within Deloitte, specialising in IDMP/structured data best practice, Data Governance and advanced use cases for the last five years.